Register information Patent

DE file number : 60 2016 051 113.4 (Status: pending/in force, Query started: July 17, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 051 113.4
96EP file numberEAKZ16 80 5522.6
86WO file numberWAKZPCT/IB2016/057073
97EP publication numberEPN3383363
87WO publication numberWPN2017093857
54Designation/titleTITOPISCHE PHARMAZEUTISCHE FORMULIERUNG ZUR BEHANDLUNG VON ENTZÜNDUNGSBEDINGTEN ERKRANKUNGEN
51IPC main classICM
(ICMV)
A61K 9/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 45/06 (2006.01), A61K 47/06 (2006.01), A61K 9/06 (2006.01), A61K 31/69 (2006.01), A61P 17/00 (2006.01)
22DE application dateDATNov 23, 2016
96EP application dateEATNov 23, 2016
86WO application dateWATNov 23, 2016
43Date of first publicationOTJun 8, 2017
Date of publication of grantPETJan 6, 2021
71/73Applicant/ownerINHAnacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US
72InventorINCORONADO, Dina Jean, Danville California 94526, US; IMBERT, Delphine Caroline, Cupertino California 95014, US; LEE, Charles Edward, Union City California 94587, US; MERCHANT, Tejal, Cupertino California 95014, US; YEP, Sylvia Zarela, Milpitas California 95035, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662420987 P
Nov 11, 2016
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562260716 P
Nov 30, 2015
Due dateFT
FG
Nov 30, 2025
Annual fee for the 10th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003383363A1
Searchable text: EP000003383363A1
Original document: EP000003383363B1
Searchable text: EP000003383363B1
Original document: WO002017093857
Searchable text: WO002017093857
43Date of first publicationEVTJun 8, 2017
Date of the first transfer into DPMAregisterEREGTOct 10, 2018
Date of the (most recent) update in DPMAregisterREGTOct 16, 2024
(Show all update days)(Hide all update days)
  • Oct 16, 2024
    • Due date: changed
  • Jul 24, 2024
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 08.06.2017: deleted
  • May 9, 2024; Jan 2, 2024; Dec 22, 2023; Oct 14, 2023; Oct 6, 2022; Sep 1, 2022; Jun 28, 2022; Dec 7, 2021; Nov 25, 2021; Apr 13, 2021; Apr 8, 2021; Jan 7, 2021; Dec 18, 2020; Dec 17, 2020; Mar 26, 2020; Aug 22, 2019; Feb 14, 2019
    • Historical data not available for this/these date(s)
  • Oct 10, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Jun 8, 2017  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Oct 10, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Nov 22, 2018 Nov 22, 2018 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 6, 2021  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Jan 28, 2021 Jan 28, 2021 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 7, 2021 Dec 30, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Aug 31, 2022 Oct 6, 2022 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTJun 8, 2017
Date of update of the procedureREGTDec 17, 2020
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTOct 10, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTNov 22, 2018
Issue numberHN47
YearPJ2018
Publication dateVTNov 22, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 6, 2021
Date of update of the procedureREGTDec 17, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJan 28, 2021
Issue numberHN4
YearPJ2021
Publication dateVTJan 28, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTJan 7, 2021
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 7, 2021
Issue numberHN52
YearPJ2021
Publication dateVTDec 30, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTDec 7, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 31, 2022
Issue numberHN40
YearPJ2022
Publication dateVTOct 6, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAnacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US
71/73Previous applicant/ownerINHFAnacor Pharmaceuticals, Inc., New York, NY, US
Date of update of the procedureREGTOct 6, 2022